PTN - Palatin Technologies Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PTN - Palatin Technologies Inc.

PTN 15.35

-0.2%

1:51 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: serndip who wrote (112)	7/18/2006 10:36:51 PM
From: rareearth42	Read Replies (1) of 142

I'd have to disagree. I think that the 2 phase 2b trials in men with results due late summer or early fall, which comprise about 800 patients total, will provide substantial evidence of efficacy and a fair assessment of toxicity, if any. If PT-141 does as well as we expect, I think it will wake up the investment community and we ought to see a substantial appreciation at that time, as one could anticipate successful phase 3 trials. RE42 P.S. I'm a former Yahoo poster who was unable to stand the new board format, shut down my Yahoo account and e-mail, and migrated here.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next